SynAct Pharma publishes Q1-2018 Report

The Board of Directors and the Chief Executive Officer of SynAct Pharma AB (publ) hereby publish Q1 2018 Report. The report is available on the company’s and Aktietorget’s websites ( and

For further information about SynAct Pharma AB, please contact:

Jeppe Øvlesen
CEO, SynAct Pharma AB
Telephone: +45 28 44 75 67
E-mail: [email protected]

Thomas Jonassen
CSO, SynAct Pharma AB
Telephone: +45 40 15 66 69